Nanogel-Facilitated In-Situ Delivery of a Cataract Inhibitor is a research paper published in Biomolecules (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: EY028147
Research to Prevent Blindness
Grant: Unrestricted research grant to Department of Ophthalmology
University of Colorado Innovations
Grant: SPARK grant
NEI NIH HHS
Grant: R01 EY028147
NEI NIH HHS
Grant: R01 EY021498
National Institutes of Health
Grant: 5R01EY028147-02
Molecular Signaling in Cataracts
National Institutes of Health
Grant: 5R21AI154360-02
Targeted Nanogel based Therapies for Chronic Recurrent Urinary Tract Infections
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals